Hologic (HOLX)
(Delayed Data from NSDQ)
$77.88 USD
-0.46 (-0.59%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $77.88 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth C Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
HOLX 77.88 -0.46(-0.59%)
Will HOLX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for HOLX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HOLX
Alphatec's (ATEC) New EOS Insight System to Boost Spine Care
Reasons to Retain DENTSPLY SIRONA (XRAY) in Your Portfolio Now
HOLX: What are Zacks experts saying now?
Zacks Private Portfolio Services
West Pharmaceutical (WST) Misses on Q2 Earnings, Lowers '24 View
Gear Up for Hologic (HOLX) Q3 Earnings: Wall Street Estimates for Key Metrics
PacBio's (PACB) Revio System to Boost Novogene's German Lab
Other News for HOLX
Hologic Completes Acquisition of Endomagnetics Ltd
$1000 Invested In Hologic 10 Years Ago Would Be Worth This Much Today
Molten Ventures to sell positions ahead of holding valuations
72 Million American Women Have Skipped or Delayed Vital Screenings
Hologic to Announce Financial Results for the Third Quarter of Fiscal 2024 on Monday, July 29, 2024